FDA Clearance Tracker · K173780
EchoMD Automated Ejection Fraction Software
Last checked: Nov 20, 2026Latest source record: Jun 14, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jun 14, 2018
Substantially Equivalent
Time to decision
184 days
Received Dec 12, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K173780
- Device name
- EchoMD Automated Ejection Fraction Software
- Applicant
- Bay Labs, Inc.
- Applicant location
- San Francisco, CA
- Received
- Dec 12, 2017
- Decided
- Jun 14, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, Image Processing, Radiological (LLZ)
- Device class
- Class II
- Regulation
- 21 CFR 892.2050
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LLZ. The earliest in FDA's data is K832895, decided Dec 8, 1983.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K173780
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bay Labs, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Caption GuidanceNew device typeBreakthroughDe Novo
DEN190040 · Decided Feb 7, 2020 · 164 days after receipt
Device type: Image Acquisition And/Or Optimization Guided By Artificial Intelligence (QJU) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.